Authorised Indian Distributor
Saxsons Group
New Delhi, India · Since 1997
Iodine-131 Therapy CapsuleRadioiodine Therapy
High-activity I-131 capsules for thyroid cancer ablation, remnant ablation after thyroidectomy, and hyperthyroidism therapy. Available in calibrated activity levels per prescription, AERB licensed for Indian hospitals.
Key Features
- High-activity I-131 capsules for thyroid cancer ablation
- Available in calibrated activity levels per prescription
- Gelatine capsule form — easy oral administration
- Certificate of Analysis with each batch — activity verification
- Shipped in lead-shielded transport container — radiation safety compliant
All Features
- High-activity I-131 capsules for thyroid cancer ablation
- Available in calibrated activity levels per prescription
- Gelatine capsule form — easy oral administration
- Certificate of Analysis with each batch — activity verification
- Shipped in lead-shielded transport container — radiation safety compliant
- AERB-licensed supply chain for Indian therapeutic nuclear medicine
- Activity calibrated to specified date and time of administration
- Compatible with standard thyroid ablation protocols
- Suitable for Graves' disease and toxic adenoma hyperthyroidism therapy
- Dosimetric activity planning support available from Saxsons team
- Suitable for outpatient (low dose) and inpatient (high dose) therapy protocols
- Full regulatory documentation for hospital pharmacy and AERB records
Technical Specifications
| Radionuclide | Iodine-131 (I-131) |
| Physical form | Oral gelatine capsule |
| Half-life | 8.02 days |
| Decay emissions | β⁻ (max 606 keV, 89%); γ 364 keV (82%) |
| Activity range | Prescription-specific; low (370 MBq) to high (7,400 MBq+) |
| Radiochemical form | Sodium iodide (NaI) in gelatin capsule |
| Radiochemical purity | ≥ 99% iodide form |
| Calibration | Activity stated at a defined reference date/time |
| Shielding | Lead pot and outer transport container per IAEA regulations |
| Stability | 14 days from calibration date (stored as directed) |
| Clinical use | Thyroid cancer ablation, remnant ablation, hyperthyroidism |
| AERB status | Licensed supply; hospital AERB authorisation required |
Applications
Radioiodine — the gold standard for thyroid disease management
Post-thyroidectomy Ablation
Destruction of residual thyroid tissue after total thyroidectomy for differentiated thyroid cancer. Standard ablation doses 1,110–3,700 MBq depending on risk stratification.
Metastatic Thyroid Cancer
High-dose I-131 therapy for loco-regional lymph node metastases and distant metastases in differentiated (papillary and follicular) thyroid carcinoma.
Hyperthyroidism — Graves'
Definitive treatment for Graves' disease with calculated or fixed-activity radioiodine dose. Long-term remission with single treatment in the majority of patients.
Toxic Multinodular Goitre
I-131 therapy for autonomous functioning thyroid nodules and toxic multinodular goitre. Reduces goitre volume and normalises thyroid function.
Remnant Ablation Monitoring
Post-ablation whole-body I-131 scanning using the therapeutic dose emission. Documents complete ablation and detects occult metastatic disease.
Outpatient Low-Dose Therapy
Low-activity I-131 (< 600 MBq) for outpatient hyperthyroidism treatment where radiation protection criteria permit discharge on day of administration.
Why Iodine-131 Therapy Capsule?
Each capsule is calibrated to the exact activity and reference time requested. Your nuclear medicine physician prescribes; the capsule arrives ready for administration — no in-house dispensing or dilution required.
I-131's β-particle (606 keV max) treats locally while the 364 keV gamma enables post-therapy whole-body scintigraphy. One radionuclide serves both the therapeutic and the imaging purpose in thyroid cancer follow-up.
Saxsons holds the required AERB import licence for I-131 therapeutic supply. Full batch documentation, transport safety data and patient administration records are provided with every order.
Reliable I-131 supply for your thyroid therapy unit
Contact Saxsons Group for prescription-specific I-131 supply, AERB documentation and therapy dose planning support across India.